Avacta Group (AVCT)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

70.50p
   
  • Change Today:
      0.50p
  • 52 Week High: 82.50p
  • 52 Week Low: 27.50p
  • Currency: UK Pounds
  • Shares Issued: 456.29m
  • Volume: 659,249
  • Market Cap: £321.68m
  • RiskGrade: 461
  • Beta: 0.01

Latest ShareCast News

Avacta meets 'important' first-quarter milestones

By Josh White

Date: Thursday 09 Apr 2026

(Sharecast News) - Avacta Therapeutics said on Thursday that it had made "important milestones" in the first quarter of 2026, as the clinical-stage oncology company advanced its preCISION platform and secured additional funding to support development through key data readouts later this year.

Avacta upbeat on preCISION comparative study

By Josh White

Date: Tuesday 24 Feb 2026

(Sharecast News) - Avacta Therapeutics said on Tuesday that new preclinical analysis indicated its proprietary 'preCISION' tumour-activated delivery platform could offer pharmacokinetic advantages over the marketed antibody drug conjugate Enhertu, as it prepared to begin a phase one trial of its lead programme AVA6103 in the first quarter of 2026.

Avacta finds new science chief internally

By Josh White

Date: Monday 09 Feb 2026

(Sharecast News) - Avacta Therapeutics announced the appointment of Francis Wilson as its chief scientific officer on Monday, effective immediately, as the AIM-traded clinical-stage biopharmaceutical company prepared for further development of its 'preCISION' tumour-activated oncology delivery platform.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Avacta Group Market Data

Currency UK Pounds
Share Price 70.50p
Change Today 0.50p
% Change 0.71 %
52 Week High 82.50p
52 Week Low 27.50p
Volume 659,249
Shares Issued 456.29m
Market Cap £321.68m
Beta 0.01
RiskGrade 461

Avacta Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average36.32% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Price Trend
37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average37.22% below the market average
13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average13.64% below the sector average
Income Not Available
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average58.62% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Avacta Group Dividends

No dividends found

Trades for 13-Apr-2026

Time Volume / Share Price
11:48 5,000 @ 69.22p
11:45 200 @ 69.22p
11:44 12,301 @ 69.22p
11:43 1,458 @ 69.13p
11:30 7,162 @ 69.75p

Avacta Group Key Personnel

CEO Christina Coughlin

Top of Page